Maternal folate metabolism plays an important role during fetal development; therefore, variation in the maternal genome may potentially impact postnatal leukemia risk, either through establishment of aberrant DNA methylation, or by directly influencing the in utero formation of preleukemic transformations such as ET6V-RUNX1 [22]. Here, RUNX1 is linked to leukemia.